Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic Acid Dose-Response in Hypertensive Patients with MTHFR Genotypes
NCT03472508Phase 4Unknown
- Sponsor
- Shenzhen Ausa Pharmaceutical
- Start
- Mar 2018
- Primary completion
- Mar 2019
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of folic acid in hyperhomocysteinemia, sponsored by Shenzhen Ausa Pharmaceutical. Status: unknown.
02
Drugs
folic acid
03
Conditions
hyperhomocysteinemia
Beyond the preview
Go deeper on NCT03472508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472508.